Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Multiple Myeloma 26Leukemia, Myeloid, Acute 24Recurrence 12Sarcoma 7Lymphoma, Large B-Cell, Diffuse 6Neoplasm Metastasis 5Neurofibrosarcoma 4Neoplasms, Plasma Cell 4Lymphoma 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Extranodal NK-T-Cell 3Lymphoma, B-Cell 3Thymoma 2Rhabdoid Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Melanoma 2Lymphoma, Mantle-Cell 2Liposarcoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Biphenotypic, Acute 2Leukemia 2Congenital Abnormalities 2Carcinoma, Non-Small-Cell Lung 2Carcinoma 2Breast Neoplasms 2Wilms Tumor 1

Interventions

Filgrastim 10Cyclophosphamide 8Granulocyte Colony-Stimulating Factor 6Melphalan 5Busulfan 5Vincristine 4Topotecan 4Temozolomide 4Stem Cell Transplantation 4Peripheral Blood Stem Cell Transplantation 4Ifosfamide 4Etoposide 4Thiotepa 3Radiotherapy 3Mesna 3Itraconazole 3Doxorubicin 3Cisplatin 3Carboplatin 3sargramostim 2fludarabine 2Therapeutics 2Sirolimus 2Radiotherapy, Intensity-Modulated 2Nivolumab 2Drug Therapy 2Bone Marrow Transplantation 2Blood Specimen Collection 2Amplified Fragment Length Polymorphism Analysis 2trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Wilms Tumor × selinexor × Clear all
NCT05985161 2026-05-06

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
GenitourinarySarcoma

Wilms Tumor, Neurofibrosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡